Sotera Health Company SHC
18.34
(0.11)
(0.60%)
as of 25 Sep
- Market cap
- $5.3B
- P/E
- 32.1×
Follow SHC
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 27.78% | 22.73% | 15.42% | 10.85% |
+8 more TTM periods Free account |
|
| 5.01% | 3.72% | 2.46% | 1.75% | ||
ROIC |
9.82% | 9.38% | 9.07% | 8.64% | |
Return on Tangible Assets |
10.33% | 7.74% | 5.22% | 3.87% | |
Average Days of Receivables |
47.61 | 44.07 | 46.21 | 49.04 | |
Free Cash Flow per Share |
0.39 | 0.34 | 0.53 | 0.30 | |
Free Cash Flow |
112.70 | 96.84 | 149.18 | 86.62 | |
Capital Expenditures |
(179.49) | (164.27) | (138.02) | (153.19) | |
Piotroski F-Score |
7.00 | 8.00 | 7.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
8.98% | 8.24% | 9.01% | 7.76% | |
Accounts Receivable Turnover |
7.93 | 8.59 | 7.91 | 7.70 | |
Accounts Payable Turnover |
6.65 | 7.25 | 7.79 | 7.66 | |
Inventory Turnover |
9.42 | 8.98 | 10.01 | 9.78 | |
Average Days of Payables |
67.33 | 52.62 | 54.93 | 44.25 | |
Days of Inventory on Hand |
37.57 | 39.45 | 38.31 | 35.94 | |
Tax Rate |
(0.38) | (0.43) | (0.47) | (0.55) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
21.15% | 21.69% | 21.72% | 22.35% | |
Share Based Compensation of Revenue |
3.05% | 3.20% | 2.65% | 2.73% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.79 | 2.22 | 3.68 | 4.33 | |
Depreciation/Fixed assets |
0.11 | 0.12 | 0.13 | 0.14 | |
Capex/Depreciation |
(1.37) | (1.24) | (0.97) | (1.02) | |
Revenue per Share |
4.26 | 4.17 | 4.10 | 4.05 | |
Operating CF per Share |
1.02 | 0.92 | 1.01 | 0.84 | |
Capex per Share |
(0.63) | (0.58) | (0.49) | (0.54) | |
Capex to Sales |
0.15 | 0.14 | 0.12 | 0.13 | |
Net Profit Margin |
13.44% | 9.91% | 6.70% | 4.81% |
Columns are period end dates